Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
“significant promise for the future of vaccine development and global health” says Clinical Trial Vanguard of the Micron, Emory and CDC collaboration on next-generation rotavirus vaccines
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology